Daiichi Sankyo Brasil Farmacêutica LTDA clinical trials

A country office of Daiichi Sankyo

The registry lists 1 studies whose lead sponsor is Daiichi Sankyo Brasil Farmacêutica LTDA. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 14, 2017.

Status

Completed: 1

Phase

Phase 3: 1

Where

Brazil: 1

Registry sponsor names on this page

Daiichi Sankyo Brasil Farmacêutica LTDA1 study

Something wrong with this grouping? Tell us on the Daiichi Sankyo page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Daiichi Sankyo studies →

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute TraumaCompletedNCT02616068Phase 3
Sponsor listed in the registry: Daiichi Sankyo Brasil Farmacêutica LTDA